David Altshuler, EVP, Chief Scientific Officer: Vertex Pharmaceuticals VRTX Sell · Filed 25/03/17

Trade details

Type: Insider sale
Amount: $1,647,810
Shares · price: 3,231 sh · $510.00 a share
Held after: 23,281 sh
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Chief Scientific Officer
Trade date: 25/03/13
Filed: 25/03/17
Days to filing: 4 days

Sold 12.2% of holdings

Share of holding sold: 12.2%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/13
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/10
Traded 25/03/10